Announcements Trials

Browse Landscape

Phase

Status

Terminated 3 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 223 Cyclophosphamide 192 Radiotherapy 183 Nivolumab 181 Carboplatin 153 Cisplatin 114 Paclitaxel 112 Dexamethasone 110 Radiosurgery 103 Magnetic Resonance Spectroscopy 97 Surveys and Questionnaires 90 Ipilimumab 81 Doxorubicin 79 Lenalidomide 76 Rituximab 75 durvalumab 74 atezolizumab 72 Radiation 72 fludarabine 68 Standard of Care 68 Gemcitabine 68 venetoclax 67 Specimen Handling 65 Etoposide 64 Capecitabine 64 Bevacizumab 62 Oxaliplatin 59 Docetaxel 58 Biopsy 58 Radiotherapy, Intensity-Modulated 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × varlilumab × Clear all

NCT03688178 2026-05-22

DERIVe

Duke University

Phase 2 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡